By Michael Balsamo and Ann D'Innocenzio

The Justice Department is suing Walmart, alleging the company unlawfully dispensed controlled substances through its pharmacies, helping to fuel the opioid crisis in America.

The civil complaint being filed Tuesday points to the role Walmart’s pharmacies may have played in the crisis by filling opioid prescriptions and by unlawfully distributing controlled substances to the pharmacies during the height of the opioid crisis. Walmart operates more than 5,000 pharmacies in its stores around the country.

The Justice Department alleges Walmart violated federal law by selling thousands of prescriptions for controlled substances that its pharmacists “knew were invalid,” said Jeffrey Clark, the acting assistant attorney general in charge of the Justice Department’s civil division.

Federal law required Walmart to spot suspicious orders for controlled substances and report those to the Drug Enforcement Administration, but prosecutors charge the company didn’t do that. Walmart couldn’t immediately be reached for comment.

“Walmart knew that its distribution centers were using an inadequate system for detecting and reporting suspicious orders,” said Jason Dunn, the U.S. attorney in Colorado. “As a result of this inadequate system, for years Walmart reported virtually no suspicious orders at all. In other words, Walmart’s pharmacies ordered opioids in a way that went essentially unmonitored and unregulated.”

The suit alleges that Walmart made it difficult for its pharmacists to follow the rules, putting “enormous pressure" on them to fill a high volume of prescriptions as fast as possible, while at the same time denying them the authority to categorically refuse to fill prescriptions issued by prescribers the pharmacists knew were continually issuing invalid prescriptions.

AP reported the news of the lawsuit ahead of the Justice Department's public announcement, citing a person who could not discuss the matter publicly before the announced move. The person spoke to the AP on condition of anonymity.

The Justice Department’s lawsuit comes nearly two months after Walmart filed its own preemptive suit against the Justice Department, Attorney General William Barr, and the Drug Enforcement Administration.

In its lawsuit, Walmart said the Justice Department’s investigation — launched in 2016 — had identified hundreds of doctors who wrote problematic prescriptions that Walmart’s pharmacists should not have filled. But the lawsuit charged that nearly 70% of the doctors still have active registrations with the DEA.

Walmart’s lawsuit alleged the government was blaming it for the lack of regulatory and enforcement policies to stem the crisis. The company is asking a federal judge to declare the suit has no basis to seek civil damages. That suit remains ongoing.

The initial investigation was the subject of a ProPublica story published in March. ProPublica reported that Joe Brown, then U.S. attorney for the Eastern District of Texas office, spent years pursuing a criminal case against Walmart for its opioid prescription practices, only to have it stymied after the retail giant’s lawyers appealed to senior officials in the Justice Department.

Two months later, Brown resigned. He didn’t give a reason for his departure except to say he would be “pursuing opportunities in the private and public sectors." Brown went into private practice in the Dallas area.

Updated on December 22, 2020, at 3:44 p.m. ET with additional details.

Share:
More In Business
Next Week on the Street: Earnings, Mosseri Testifies, Blue Origin Launch
Earnings season continues in the week of December 6 - 10, and that's only the start of a slate of events on the calendar that may move markets. We will also see executives from the crypto world and Instagram Head Adam Mosseri testify before members of Congress, and Square's name change to Block officially goes into effect.
Stocks Close the Week Lower on Mixed Jobs Report, COVID-19 Omicron Variant Volatility
Stocks closed lower Friday after a volatile week that saw investor skittishness over the COVID-19 omicron variant. Investors were also eyeing the mixed November jobs report, which showed a lower than expected number of 210,000 jobs added, but unemployment falling to 4.2%. Aadil Zaman, Partner at Wall Street Alliance Group, joins Cheddar News' Closing Bell to discuss today's close, the mixed jobs report, what impact the omicron variant could have on markets, and more.
Some U.S. Restaurants Are Pausing Online Delivery Orders During Peak Hours
Many restaurants across the country have lately turned off delivery and online orders during peak hours, as eateries are still struggling with labor shortages and as many are also seeing more customers return for in-person dining. Wall Street Journal reporter Heather Haddon joins Cheddar News' Closing Bell to discuss.
Mixed November Jobs Report Shows Hiring Slump, But Lower Unemployment Rate
November's jobs report is tricky: nonfarm payrolls only increased by 210,000, following an October gain of 546,000. At the same time, the unemployment rate fell to 4.2% - and the labor force participation rate rose 61.8% to its highest level since March 2020. Also of note: the retail sector saw a decline of 20,000 jobs despite what was once a traditional late fall push to hire before the holiday sales rush. What's going on in the labor market, and can we expect more volatile numbers as the omicron variant spreads during the winter months? Adam Ozimek, Chief economist at Upwork, joins Cheddar News' Closing Bell to discuss the mixed jobs report, sector winners and losers, retail's flip-flop, and more.
DiDi Delisting Could Signal Forced Decoupling of China-U.S. in Financial Markets
Chinese regulators are reportedly behind China-based ride-hailing company DiDi exiting from the New York Stock Exchange, just days after listing earlier this year. The regulators stated prior that DiDi had not received the necessary clearances to list in the states. Gordon Chang, Asian affairs expert, joined Cheddar to break down what the delisting says about the relationship between nations. "This really strikes me as an attempt to really to force a decoupling of China and the U.S. in the financial markets," Chang said.
Load More